Venture Capital

The role of technology providers in biotech

Read more

Investment pendulum swings back towards biotech

Read more

Shire Plc adds new dimension to its strategy

Read more

Shortage of risk capital keeps befuddling markets

Read more

Capital efficiency -- a new norm

Read more

Launch of Takeda Ventures

Read more

Boehringer Ingelheim opts for nimble approach

Read more

Corporate venture capital shifts to a higher gear

Read more

Getting in the loop with Bicycle Therapeutics

Read more

Alternative funding strategies for biotech

Read more